Zhaoting Li

2.3k total citations · 3 hit papers
49 papers, 1.8k citations indexed

About

Zhaoting Li is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Zhaoting Li has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Immunology and 16 papers in Oncology. Recurrent topics in Zhaoting Li's work include Nanoplatforms for cancer theranostics (10 papers), Immunotherapy and Immune Responses (8 papers) and RNA Interference and Gene Delivery (5 papers). Zhaoting Li is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Immunotherapy and Immune Responses (8 papers) and RNA Interference and Gene Delivery (5 papers). Zhaoting Li collaborates with scholars based in China, United States and Australia. Zhaoting Li's co-authors include Yixin Wang, Quanyin Hu, Jun Liu, Yingyue Ding, Minjie Sun, Yu Chen, Fanyi Mo, Seungpyo Hong, David Oupický and Ana Jaklenec and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Zhaoting Li

47 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemically and Biologically Engineered Bacteria‐Based Delivery Systems for Emerging Diagnosis and Advanced Therapy

2021 191 citations Zhaoting Li, Yixin Wang et al. profile →
Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases

2022 176 citations Jun Liu, Yixin Wang et al. Science Advances profile →
Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment

2022 148 citations Zhaoting Li, Yingyue Ding et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhaoting Li China	21	699	675	577	371	246	49	1.8k
Yixin Wang United States	19	776 1.1×	722 1.1×	462 0.8×	337 0.9×	283 1.2×	40	1.8k
Jiaqi Xu China	16	812 1.2×	855 1.3×	363 0.6×	167 0.5×	371 1.5×	30	1.9k
John W. Hickey United States	18	879 1.3×	460 0.7×	592 1.0×	527 1.4×	221 0.9×	48	1.9k
Anvay Ukidve United States	15	869 1.2×	812 1.2×	467 0.8×	250 0.7×	658 2.7×	17	2.2k
Hao Qin China	19	810 1.2×	891 1.3×	437 0.8×	404 1.1×	576 2.3×	34	1.9k
Davoud Ahmadvand Iran	25	877 1.3×	520 0.8×	449 0.8×	416 1.1×	475 1.9×	68	1.9k
Jinsheng Huang China	27	754 1.1×	848 1.3×	395 0.7×	287 0.8×	406 1.7×	67	2.0k
Min Luo China	16	820 1.2×	786 1.2×	1.2k 2.1×	427 1.2×	289 1.2×	25	2.0k
Siddharth Jhunjhunwala India	27	1.4k 2.0×	866 1.3×	468 0.8×	208 0.6×	438 1.8×	56	2.8k
Ying‐Li Luo China	22	1.1k 1.6×	625 0.9×	440 0.8×	256 0.7×	407 1.7×	37	1.9k

Countries citing papers authored by Zhaoting Li

Since Specialization

Citations

This map shows the geographic impact of Zhaoting Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoting Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoting Li more than expected).

Fields of papers citing papers by Zhaoting Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoting Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoting Li. The network helps show where Zhaoting Li may publish in the future.

Co-authorship network of co-authors of Zhaoting Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoting Li. A scholar is included among the top collaborators of Zhaoting Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoting Li. Zhaoting Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Zhaoting, et al.. (2025). Engineering pyroptotic vesicles as personalized cancer vaccines. Nature Nanotechnology. 20(8). 1108–1118. 7 indexed citations

Li, Fucheng, Tian Gao, Zhaoting Li, et al.. (2025). Triglyceride-glucose index and triglyceride-glucose–body mass index as prognostic factors for early stage breast cancer patients receiving neoadjuvant chemotherapy. Translational Oncology. 53. 102292–102292. 1 indexed citations

Yu, Jie, et al.. (2025). Engineered bacteria and bacterial derivatives as advanced therapeutics for inflammatory bowel disease. Essays in Biochemistry. 69(2). 169–179. 3 indexed citations

Yu, Jian‐Qiang, Zhaoting Li, Chen Shen, Hongsheng Gao, & Lixia Sheng. (2024). Analysis of Ethylene Signal Regulating Sucrose Metabolism in Strawberry Fruits Based on RNA-seq. Plants. 13(8). 1121–1121. 4 indexed citations

Chen, Ming, et al.. (2024). Transcriptome and metabolome analyses reveal the effects of brassinolide treatment on the ripening and flavor development of postharvest kiwifruit. Postharvest Biology and Technology. 222. 113380–113380.

Xu, Linghui, Zhaoting Li, Li Mei Pang, et al.. (2024). A PilZ domain protein interacts with the transcriptional regulator HinK to regulate type VI secretion system in Pseudomonas aeruginosa. Journal of Biological Chemistry. 300(3). 105741–105741. 5 indexed citations

Li, Zhaoting, Fanyi Mo, Kai Guo, et al.. (2024). Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer. Med. 5(4). 348–367.e7. 14 indexed citations

Li, Zhaoting, Yueyang Deng, Honghao Sun, et al.. (2023). Redox modulation with a perfluorocarbon nanoparticle to reverse Treg-mediated immunosuppression and enhance anti-tumor immunity. Journal of Controlled Release. 358. 579–590. 17 indexed citations

Wang, Hongye, et al.. (2023). An efficient and mild oxidative approach from thiols to sulfonyl derivatives with DMSO/HBr. Chemical Science. 14(45). 13228–13234. 6 indexed citations

10.

Wang, Yixin, et al.. (2023). Nano-STING agonist-decorated microrobots boost innate and adaptive anti-tumor immunity. Nano Research. 16(7). 9848–9858. 13 indexed citations

11.

Li, Zhaoting, Fanyi Mo, Yixin Wang, et al.. (2022). Enhancing Gasdermin-induced tumor pyroptosis through preventing ESCRT-dependent cell membrane repair augments antitumor immune response. Nature Communications. 13(1). 6321–6321. 94 indexed citations

12.

Li, Zhaoting, Yingyue Ding, Jun Liu, et al.. (2022). Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment. Nature Communications. 13(1). 1845–1845. 148 indexed citations breakdown →

13.

Sun, Weiming, Jingjing Song, Wentao Zhao, et al.. (2022). Bibliometric and visual analysis of transcranial direct current stimulation in the web of science database from 2000 to 2022 via CiteSpace. Frontiers in Human Neuroscience. 16. 1049572–1049572. 11 indexed citations

14.

Ding, Yingyue, Zhaoting Li, Ana Jaklenec, & Quanyin Hu. (2021). Vaccine delivery systems toward lymph nodes. Advanced Drug Delivery Reviews. 179. 113914–113914. 134 indexed citations

15.

Li, Zhaoting, Yixin Wang, Yuexin Shen, et al.. (2020). Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy. Science Advances. 6(20). eaaz9240–eaaz9240. 144 indexed citations

16.

Li, Zhaoting, Yuexin Shen, Yixin Wang, et al.. (2019). Perfluorocarbon Nanoemulsions for Combined Pulmonary siRNA Treatment of Lung Metastatic Osteosarcoma. Advanced Therapeutics. 2(7). 14 indexed citations

17.

Li, Zhaoting, Gang Chen, Ling Ding, et al.. (2019). Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions. Molecular Therapy. 27(12). 2100–2110. 39 indexed citations

18.

Chen, Gang, Yixin Wang, Pengkai Wu, et al.. (2018). Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer. ACS Nano. 12(7). 6620–6636. 50 indexed citations

19.

Li, Junsheng, Hui Huang, Yongjiang Zhou, Chaoyang Zhang, & Zhaoting Li. (2017). Research progress of graphene-based microwave absorbing materials in the last decade. Journal of materials research/Pratt's guide to venture capital sources. 32(7). 1213–1230. 70 indexed citations

20.

Zhang, Shuguang, et al.. (2004). Combined devascularization and proximal splenorenal shunt: is this a better option than either procedure alone?. Journal of Hepato-Biliary-Pancreatic Surgery. 11(2). 129–134. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact